Search results for: Health Policy and Regulation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

2 June 2023

…objectives and policy initiatives that can facilitate progress and increase uptake: The introduction of appropriate pricing and reimbursement mechanisms The standardisation of testing and care pathways The development of infrastructure…

2022 Innovation Policy Prize

…our inaugural question ‘How can policymakers design a system to generate fair prices that balances access and innovation throughout the lifecycle of medicines?’ All our finalists have created novel and unique solutions to tackle an important issue. Our ambition for the OHE Policy Prize is that by incentivising new and independent research,…

Public Preferences for Health Gains and Cures: A Discrete Choice Experiment

1 January 2019

…important area for research. The aim of this research was thus to explore society’s preferences across curative and non-curative therapies and large and small health gains, via a discrete choice…

An Update on the EQ-5D-5L Value Set for England

22 August 2017

…and academic health economists. All aspects of the data and modelling were reported to the steering group members at regular meetings, and their guidance was sought on the modelling approaches…

Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England

1 March 2019

…and mortality. DEA was applied to health outcomes and health expenditure data from 151 Primary Care Trusts (PCTs) (now Clinical Commissioning Groups) in England across seven clinical areas termed Programme…

Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England

20 March 2019

…between health outcomes and health expenditures in England. Results suggest that setting a cost-effectiveness criterion for NICE may not be capable of being synthesised using scientific methods alone, but involve…

Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics

16 January 2024

…options 1 and 2 and seems to indicate that they are plausible pathways (European Commission, European Health and Digital Executive Agency, 2023). Elsewhere, member states have suggested the Health Emergency Preparedness and Response…

Unlocking the Value of Combination Therapies

9 July 2024

…fairness in value attribution shares, feasibility, uncertainty of inputs and outputs, and accuracy in cases of sub- or super-additivity. IV was seen as the simplest and most feasible but insufficient…

Why Care About Health Inequality?

1 January 2001

…illness; to improve the health of the worst off in society and to narrow the health gap. This monograph looks at health inequalities in the UK from a health economics…